Neuronetics, Inc. announced preliminary unaudited sales results for the fourth quarter and full year of 2020. For the quarter,preliminary unaudited revenue between $15.0 and $15.5 million compared to previously issued guidance of $13.0 and $13.5 million. This represents a sequential increase of between 21% and 25% compared to third quarter 2020. For the full year, the company reported revenue between $48.7 and $49.2 million, representing a decrease of approximately 22% and 21%, respectively, when compared with $62.7 million for the full year 2019 due to the impact of COVID-19.